New hope for Tough-to-Treat schizophrenia: experimental drug enters final testing phase
Disease control
Recruiting now
This study is testing whether adding a new drug called evenamide helps people with schizophrenia when their current antipsychotic medications aren't working well enough. About 400 adults whose schizophrenia hasn't responded to standard treatments will take either evenamide or a p…
Phase: PHASE3 • Sponsor: Newron Pharmaceuticals SPA • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC